AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

“Emphysema makes it hard to breathe air out of your lungs as it affects the tiny air sacs at the end of the airways where ...

A viral outbreak in China is raising concerns reminiscent of 2019, but this time the focus is on human metapneumovirus (HMPV) ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...

More than a week after a series of wildfires broke out in and around Los Angeles, winds are starting to let up, giving ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Winter is closely linked to an increase in respiratory infections, as it is considered a season of heightened allergies and ...

EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & Royalty Sex & Love ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

A psychoeducational intervention for extrapulmonary manifestations of severe asthma was found feasible and rated as ...